UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Impact of hydroxyurea on clinical events in the BABY HUG trial

Blood, 2012-11, Vol.120 (22), p.4304-4310

2012

Volltextzugriff (PDF)

Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography

The New England journal of medicine, 1998-07, Vol.339 (1), p.5-11

1998

Volltextzugriff (PDF)

Oral citrulline as arginine precursor may be beneficial in sickle cell disease: Early phase two results

Journal of the National Medical Association, 2001-10, Vol.93 (10), p.363-371

2001

Volltextzugriff (PDF)

Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: Two‐year results including pharmacokinetics and concomitant hydroxyurea

American journal of hematology, 2013-12, Vol.88 (12), p.1068-1073

2013

Volltextzugriff (PDF)

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease

British journal of haematology, 2007-02, Vol.136 (3), p.501-508

2007

Volltextzugriff (PDF)

Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trial

Contemporary clinical trials, 2012-03, Vol.33 (2), p.291-297

2012

Volltextzugriff (PDF)

A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy

Blood, 2011-11, Vol.118 (21), p.1082-1082

2011

Volltextzugriff (PDF)

Inpatient management of sickle cell pain: A 'snapshot' of current practice

American journal of hematology, 2012-03, Vol.87 (3), p.333-336

2012

Volltextzugriff (PDF)

Reduced Incidence of Acute Chest Syndrome (ACS) in Pediatric Patients Followed in a Comprehensive Sickle Cell Pulmonary Clinic

Chest, 2004-10, Vol.126 (4), p.778S-778S

2004

Volltextzugriff (PDF)

Stroke risk in siblings with sickle cell anemia

Blood, 2003-03, Vol.101 (6), p.2401-2404

2003

Volltextzugriff (PDF)

Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial

JAMA : the journal of the American Medical Association, 2001-11, Vol.286 (17), p.2099

2001

Volltextzugriff (PDF)

Chronic transfusion practice for children with sickle cell anaemia and stroke

British journal of haematology, 2009-05, Vol.145 (4), p.524-528

2009

Volltextzugriff (PDF)

Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial

Acta haematologica, 2008, Vol.119 (3), p.133-141

2008

Volltextzugriff (PDF)

A multicenter randomised controlled trial of hydroxyurea (hydroxycarbamide) in very young children with sickle cell anaemia

The Lancet (British edition), 2011-05, Vol.377 (9778), p.1663-1672

2011

Volltextzugriff (PDF)

Sudden onset blindness in sickle cell disease due to retinal artery occlusion

Pediatric blood & cancer, 2008-03, Vol.50 (3), p.624-627

2008

Volltextzugriff (PDF)

Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

Blood, 2008-11, Vol.112 (11), p.1416-1416

2008

Volltextzugriff (PDF)

Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease

Blood, 2007-11, Vol.110 (11), p.429-429

2007

Volltextzugriff (PDF)

Longitudinal changes in ferritin during Chronic transfusion: A report from the stroke prevention trial in sickle cell anemia (STOP)

Journal of pediatric hematology/oncology, 2002-05, Vol.24 (4), p.284-290

2002

Volltextzugriff (PDF)

Secretory Phospholipase A2 Levels in Patients with Sickle Cell Disease and Acute Chest Syndrome

Hemoglobin, 2006, Vol.30 (2), p.165-170

2006

Volltextzugriff (PDF)

Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis

Acta haematologica, 2008-06, Vol.119 (3), p.133-141

2008

Volltextzugriff (PDF)

Safety of Purified Poloxamer 188 in Sickle Cell Disease: Phase I Study of a Non-ionic Surfactant in the Management of Acute Chest Syndrome

Hemoglobin, 2004-01, Vol.28 (2), p.85-102

2004

Volltextzugriff (PDF)

Pharmacokinetics of Hydroxyurea in Young Children with Sickle Cell Anemia: A Report from the BABY HUG Trial

Blood, 2005-11, Vol.106 (11), p.3184-3184

2005

Volltextzugriff (PDF)

LANGERHANS CELL HISTIOCYTOSIS: Central Nervous System Involvement Treated Successfully with 2-Chlorodeoxyadenosine

Pediatric hematology and oncology, 2001, Vol.18 (3), p.199-203

2001

Volltextzugriff (PDF)

Secretory Phospholipase A 2 Levels in Patients with Sickle Cell Disease and Acute Chest Syndrome

Hemoglobin, 2006-01, Vol.30 (2), p.165-170

2006

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(22)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Male
(18)
Biological And Medical Sciences
(16)
Child
(16)
Medical Sciences
(16)
Adolescent
(15)
Female
(15)
Adult
(11)
Hematologic And Hematopoietic Diseases
(11)
Anemia, Sickle Cell - Complications
(10)
Child, Preschool
(10)
Hematology
(10)
Anemias. Hemoglobinopathies
(8)
Diseases Of Red Blood Cells
(8)
Anemia, Sickle Cell - Therapy
(7)
Sickle Cell Anemia
(7)
Anemia, Sickle Cell - Blood
(6)
Anemia, Sickle Cell - Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of hydroxyurea on clinical events in the BABY HUG trial

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography

Oral citrulline as arginine precursor may be beneficial in sickle cell disease: Early phase two results

Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: Two‐year results including pharmacokinetics and concomitant hydroxyurea

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease

Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trial

A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy

Inpatient management of sickle cell pain: A 'snapshot' of current practice

Reduced Incidence of Acute Chest Syndrome (ACS) in Pediatric Patients Followed in a Comprehensive Sickle Cell Pulmonary Clinic

Stroke risk in siblings with sickle cell anemia

Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial

Chronic transfusion practice for children with sickle cell anaemia and stroke

Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial

A multicenter randomised controlled trial of hydroxyurea (hydroxycarbamide) in very young children with sickle cell anaemia

Sudden onset blindness in sickle cell disease due to retinal artery occlusion

Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease

Longitudinal changes in ferritin during Chronic transfusion: A report from the stroke prevention trial in sickle cell anemia (STOP)

Secretory Phospholipase A2 Levels in Patients with Sickle Cell Disease and Acute Chest Syndrome

Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis

Safety of Purified Poloxamer 188 in Sickle Cell Disease: Phase I Study of a Non-ionic Surfactant in the Management of Acute Chest Syndrome

Pharmacokinetics of Hydroxyurea in Young Children with Sickle Cell Anemia: A Report from the BABY HUG Trial

LANGERHANS CELL HISTIOCYTOSIS: Central Nervous System Involvement Treated Successfully with 2-Chlorodeoxyadenosine

Secretory Phospholipase A 2 Levels in Patients with Sickle Cell Disease and Acute Chest Syndrome

Suchergebnisse filtern